Kenvue Inc. Defends Tylenol Amid Regulatory Scrutiny, Shares Surge
Kenvue Inc., the maker of Tylenol, is navigating a high-profile regulatory scrutiny over alleged links between its pain-relief product and autism spectrum disorders, but its proactive engagement and comprehensive defense strategy have helped boost i…
3 minutes to read